Nuclear and cytoplasmic fractionation experiments followed by Western blotting, confirmed that silencing LEF1 reduced the nuclear pool of β-catenin in the established colon cancer cell line DLD1 (Fig. 3d) and in HCEC-APC (Fig. 3e). Here, LEF1 is linked to malignant colon neoplasm.